NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
6.00
-0.20 (-3.23%)
Oct 22, 2024, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $175.18 million as of October 23, 2024. Its market cap has decreased by -3.37% in one year.
Market Cap
175.18M
Enterprise Value
193.30M
1-Year Change
-3.37%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $175.18M, a decrease of -55.46%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 175.20M | -35.35% |
| Dec 29, 2023 | 271.00M | 630.46% |
| Dec 30, 2022 | 37.10M | -84.86% |
| Dec 31, 2021 | 245.10M | -37.68% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 191.87M |
| Sangamo Therapeutics | 191.71M |
| Kodiak Sciences | 190.00M |
| MediWound | 189.63M |
| Accuray | 189.52M |
| MultiPlan | 188.55M |
| Semler Scientific | 188.51M |
| Black Diamond Therapeutics | 187.03M |